These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 6336925)

  • 21. Rat lung lavage surfactant enhances bacterial phagocytosis and intracellular killing by alveolar macrophages.
    O'Neill S; Lesperance E; Klass DJ
    Am Rev Respir Dis; 1984 Aug; 130(2):225-30. PubMed ID: 6547813
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of trehalose in resistance to macrophage killing: study with a tps1/tps1 trehalose-deficient mutant of Candida albicans.
    Martínez-Esparza M; Aguinaga A; González-Párraga P; García-Peñarrubia P; Jouault T; Argüelles JC
    Clin Microbiol Infect; 2007 Apr; 13(4):384-94. PubMed ID: 17359322
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Candidacidal factors in murine bronchoalveolar lavage fluid.
    Nugent KM; Fick RB
    Infect Immun; 1987 Mar; 55(3):541-6. PubMed ID: 3818084
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Collection and cultivation of and phagocytosis by pulmonary macrophages obtained from hysterectomy-derived pigs.
    Williams PP
    Am J Vet Res; 1978 Mar; 39(3):485-9. PubMed ID: 345891
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Interaction of Candida albicans with macrophages].
    Karaev ZO; Pokrovskaia OL
    Zh Mikrobiol Epidemiol Immunobiol; 1988 Feb; (2):87-91. PubMed ID: 3284257
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pulmonary defence mechanism in mice. A comparative role of alveolar macrophages and polymorphonuclear cells against infection with Candida albicans.
    Lal S; Mitsuyama M; Miyata M; Ogata N; Amako K; Nomoto K
    J Clin Lab Immunol; 1986 Mar; 19(3):127-33. PubMed ID: 3519975
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enhanced killing of Candida albicans by murine macrophages treated with macrophage colony-stimulating factor: evidence for augmented expression of mannose receptors.
    Karbassi A; Becker JM; Foster JS; Moore RN
    J Immunol; 1987 Jul; 139(2):417-21. PubMed ID: 3298429
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modulation of anti-Candida activity of human alveolar macrophages by interferon-gamma or interleukin-1-alpha.
    Vecchiarelli A; Todisco T; Puliti M; Dottorini M; Bistoni F
    Am J Respir Cell Mol Biol; 1989 Jul; 1(1):49-55. PubMed ID: 2516451
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phagocytic activity of LPS tolerant macrophages.
    de Lima TM; Sampaio SC; Petroni R; Brigatte P; Velasco IT; Soriano FG
    Mol Immunol; 2014 Jul; 60(1):8-13. PubMed ID: 24732064
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phagocytosis of Candida albicans by alveolar macrophages from patients with cystic fibrosis.
    Sordelli DO; Cassino RJ; Macri CN; Kohan M; Dillon MH; Pivetta OH
    Clin Immunol Immunopathol; 1982 Feb; 22(2):153-8. PubMed ID: 7049458
    [No Abstract]   [Full Text] [Related]  

  • 31. Influence of aging on murine neutrophil and macrophage function against Candida albicans.
    Murciano C; Yáñez A; O'Connor JE; Gozalbo D; Gil ML
    FEMS Immunol Med Microbiol; 2008 Jul; 53(2):214-21. PubMed ID: 18445021
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human and rabbit newborn lung macrophages have reduced anti-Candida activity.
    D'Ambola JB; Sherman MP; Tashkin DP; Gong H
    Pediatr Res; 1988 Sep; 24(3):285-90. PubMed ID: 3062557
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of a mannose binding protein on macrophage interactions with Candida albicans.
    Kitz DJ; Stahl PD; Little JR
    Cell Mol Biol; 1992 Jul; 38(4):407-12. PubMed ID: 1499040
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Kinetics of phagocytosis and killing of E. coli by murine macrophages in presence of different serum preparations.
    Adinolfi LE; Dilillo M; Tripodi MF; Utili R; Bonventre PF; Ruggiero G
    Microbiologica; 1988 Jan; 11(1):13-20. PubMed ID: 3280948
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Defective candidacidal activity of alveolar macrophages and peripheral blood monocytes from patients with chronic obstructive pulmonary disease.
    Vecchiarelli A; Dottorini M; Puliti M; Todisco T; Cenci E; Bistoni F
    Am Rev Respir Dis; 1991 May; 143(5 Pt 1):1049-54. PubMed ID: 1902635
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanisms of complement-mediated clearance of bacteria from the murine lung.
    Heidbrink PJ; Toews GB; Gross GN; Pierce AK
    Am Rev Respir Dis; 1982 May; 125(5):517-20. PubMed ID: 7081809
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Candida albicans metabolite affects the cytoskeleton and phagocytic activity of murine macrophages.
    Schindler B; Segal E
    Med Mycol; 2008 May; 46(3):251-8. PubMed ID: 18404553
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhancement of macrophage candidacidal activity by interferon-gamma.
    Maródi L; Johnston RB
    Immunodeficiency; 1993; 4(1-4):181-5. PubMed ID: 8167696
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro immunity of rat peritoneal macrophages to Candida albicans.
    Joshi KR; Joshi H
    Indian J Chest Dis Allied Sci; 2000; 42(4):341-4. PubMed ID: 15597683
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pulmonary tissue resistance to Candida albicans in normal and in immunosuppressed mice.
    Nugent KM; Onofrio JM
    Am Rev Respir Dis; 1983 Nov; 128(5):909-14. PubMed ID: 6638681
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.